Kaleo Inc. agreed to pay $12.7 million to resolve allegations that the Virginia-based pharmaceutical manufacturer caused the submission of false claims for the drug Evzio, an injectable form of naloxone hydrochloride used to reverse opioid overdoses, according to a Justice Department news release.
The Justice Department alleges that between March 14, 2017, and April 30, 2020, the company directed prescribing doctors to send Evzio prescriptions to certain preferred pharmacies that in turn submitted false prior authorization requests for the drug. The U.S. also alleged the company provided illegal remuneration to prescribing physicians and their office staff in violation of ...
OAKLAND, Calif. — Hobby Lobby dodged unjust enrichment, but not false advertising, claims brought by consumers who say the company’s “limited time” sales are misleading because the discounted items...